MedTrace Logo

Effectiveness and Safety of STYLAGE® XXL for Chin Augmentation in Chinese Adults

NCT05009381 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 174

Last updated 2023-09-21

No results posted yet for this study

Summary

The aim of this trial is to demonstrate the efficacy and safety of STYLAGE® XXL in augmenting the chin volume among Chinese adults.

Subjects will be randomized either to the treatment group or the control group in a 4:1 ratio

The superiority of STYLAGE® XXL against no-treatment control in chin volume augmentation will be verified together with assessments of the safety profiles.

Conditions

  • Esthetic

Interventions

DEVICE

Stylage XXL at enrollment

Injection in the chin at enrollment

DEVICE

Stylage XXL at Month 6

Injection in the chin 6 months after randomization

Sponsors & Collaborators

  • Laboratoires Vivacy

    lead INDUSTRY

Principal Investigators

  • Yan Wu · Peking University First Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-10
Primary Completion
2022-10-26
Completion
2023-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05009381 on ClinicalTrials.gov